Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals

被引：0
|
作者：
Kathryn J. Eagye
David P. Nicolau
机构：
[1] Hartford Hospital,Center for Anti
[2] Hartford Hospital,Infective Research and Development
[3] Hartford Hospital,Center for Anti
来源：
Advances in Therapy | 2011年 / 28卷
关键词：
antimicrobial resistance; fluoroquinolones; imipenem;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：326 / 333
页数：7
相关论文
共 50 条
  • [41] Fluoroquinolone (FQ) Use and Resistance to Pseudomonas aeruginosa among US Academic Medical Centers
    Pakyz, Amy
    Lee, Jin
    Harpe, Spencer
    Medvedev, Sofia
    Polk, Ron
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S190 - S190
  • [42] Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study
    Lafaurie, Matthieu
    Porcher, Raphael
    Donay, Jean-Luc
    Touratier, Sophie
    Molina, Jean-Michel
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (04) : 1010 - 1015
  • [43] Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa
    Wang, J
    Hu, B
    Xu, MC
    Yan, Q
    Liu, SY
    Zhu, XH
    Sun, Z
    Reed, E
    Ding, L
    Gong, JP
    Li, QDQ
    Hu, JB
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 17 (02) : 309 - 317
  • [44] SELECTIVE IMIPENEM RESISTANCE IN PSEUDOMONAS-AERUGINOSA ASSOCIATED WITH DIMINISHED OUTER-MEMBRANE PERMEABILITY
    STUDEMEISTER, AE
    QUINN, JP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) : 1267 - 1268
  • [45] Imipenem resistance associated with amino acid alterations of the OprD porin in Pseudomonas aeruginosa clinical isolates
    Nazari, Maryam
    Ahmadi, Hadi
    Hosseinzadeh, Shahnaz
    Sahebkar, Amirhossein
    Khademi, Farzad
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2023, 70 (03) : 206 - 212
  • [46] SUCCESSFUL USE OF HIGHER-THAN-RECOMMENDED DOSAGE OF IMIPENEM IN PSEUDOMONAS-AERUGINOSA ENDOCARDITIS
    KING, JH
    KAILATH, EJ
    HRDY, DB
    ANNALS OF PHARMACOTHERAPY, 1992, 26 (05) : 639 - 641
  • [47] Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa
    Cabot, Gabriel
    Kim, Kihun
    Mark, Brian L. L.
    Oliver, Antonio
    Khajehpour, Mazdak
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (02)
  • [48] USE OF CEFOTAXIME OR CEFTAZIDIME SUSCEPTIBILITY TESTS FOR PREDICTING SUSCEPTIBILITY OF ENTEROBACTERIACEAE AND PSEUDOMONAS-AERUGINOSA
    HEYM, B
    LACROIX, O
    PEAN, Y
    GERTNER, J
    NICOLAS, MH
    JARLIER, V
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (04) : 729 - 735
  • [49] PSEUDORESISTANCE OF PSEUDOMONAS-AERUGINOSA RESULTING FROM DEGRADATION OF IMIPENEM IN AN AUTOMATED SUSCEPTIBILITY TESTING SYSTEM WITH PREDRIED PANELS
    WHITE, RL
    KAYS, MB
    FRIEDRICH, LV
    BROWN, EW
    KOONCE, JR
    JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (02) : 398 - 400
  • [50] Determining the distribution of the blaVIM gene in imipenem-resistant Pseudomonas aeruginosa strains isolated from three different hospitals
    Ozyurek, Sezen B.
    Bilkay, Isil S.
    MINERVA BIOTECNOLOGICA, 2016, 28 (01) : 52 - 58
12345